The emerging Eastern European pharmaceutical markets are growing much faster than established Western European economies, at an average growth rate of 7 percent. On the eve of the EU accession last year, Romania had the fastest growth rate in the region. Pharmaceutical and health care spending is still relatively low, but pressure to move in line with EU requirements and become an integral part of international pharmaceutical operations will boost spending signifi cantly over the next few years.
